Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-05-15 | New | $10,000,000 | $10,000,000 | Equity Only | 06b | SEC link |
2024-07-01 | New | $16,998,224 | $16,998,224 | Equity Only | 06b | SEC link |
2021-10-18 | New | $14,000,002 | $14,000,002 | Equity Only | 06b | SEC link |
2021-02-01 | New | $10,000,000 | $10,000,000 | Equity Only | 06b | SEC link |
2021-01-12 | New | $17,030,344 | $17,030,344 | Equity Only | 06b | SEC link |
2017-03-30 | New | $12,540,704 | $12,540,704 | Equity Only | 06b | SEC link |
2016-04-27 | Amended | $10,601,500 | $5,000,000 | Debt Only | 06b | SEC link |
2016-03-10 | Amended | $5,601,500 | $150,500 | Debt Only | 06b | SEC link |
2015-12-22 | Amended | $5,451,000 | $2,650,000 | Debt Only | 06b | SEC link |
2015-08-07 | New | $2,801,000 | $2,801,000 | Debt Only | 06b | SEC link |
2015-08-07 | Amended | $2,801,000 | $0 | Debt Only | 06b | SEC link |
2015-04-15 | New | $5,000,000 | $5,000,000 | Equity Only | 06b | SEC link |
2015-04-08 | New | $2,739,049 | $2,739,049 | Debt Only | 06b | SEC link |
Name | Role |
---|---|
Akash Bakshi | Executive |
Andrew Bartynski | Executive |
Charles Bisgaier | Director, Executive |
Mark A. Glickman | Director |
Lee S. Golden | Executive |
Jason L. Groves | Director |
Steve Gullans | Director |
Stephen Haakenson | Director |
P. Kent Hawryluk | Director |
Richard J. Kang | Director, Executive |
Hyung Heon Kim | Director, Executive |
Na Yeon Kim | Director |
Kenneth Kousky | Director |
Andrew Koven | Director |
Pedro Lichtinger | Director |
David Lowenschuss | Executive |
Nadja Mannowetz | Executive |
Jeffrey Mathiesen | Executive |
Margaret Mc Shane | Executive |
Jeong Gyun Oh | Director |
Daniela Oniciu | Executive |
Seth Reno | Executive |
Michael Salsbury | Director |
Andy Sassine | Director |
Nicola Shannon | Executive |
Mina Sooch | Director, Executive |
D. Gordon Strickland | Director |
Douglas J. Swirsky | Director |
James P. Tursi | Director |
Marshall H. Woodworth | Executive |
Amy Zaremba Rabourn | Director |